Format

Send to

Choose Destination
Gan To Kagaku Ryoho. 2012 Mar;39(3):337-41.

[Borderline resectable pancreatic cancer - a definition and effective treatment strategy].

[Article in Japanese]

Author information

1
Dept. of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Abstract

The survival benefit of extended surgery for advanced pancreatic cancer has been denied by four randomized controlled trials. However, there still is confusion and conflict over the definition and effective treatment strategy for so-called locally advanced or borderline resectable pancreatic cancer. Although there are a number of reports that showed outcomes of preoperative chemotherapy or chemoradiotherapy for this disease, the definitions and treatment regimens described in these studies vary. Moreover, all of the studies were Phase I / II trials or retrospective analysis, and there is no Phase III trial currently focused on this issue. It is urgently necessary to establish an international consensus on the definition of borderline resectable pancreatic cancer. The usefulness of neoadjuvant treatment for this disease should also be elucidated in future clinical trials. In this review article, we discuss the current understanding and definition of borderline resectable pancreatic cancer, and the value of neoadjuvant treatment strategy for treating it.

PMID:
22421757
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Sunmedia PierOnline
Loading ...
Support Center